Opus Genetics IRD
NASDAQ IRD
$4.01 +0.19 (+4.97%)
At close: Oct 20, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Operating Leases (2019 - 2020)

Updated

Opus Genetics (IRD) reported Operating Leases of $25,790 for Q1 2020, down 85.8% from $181,490 a year earlier and down 59.5% from the prior quarter.

Analysis

Opus Genetics (IRD) Operating Leases (2019 - 2020) Analysis & Trends

At the end of FY2019, Opus Genetics posted Operating Leases of $63,605.

  • Per Business Quant data, the three quarters before Q1 2020 came in at $63,605 (Q4 2019), $100,397 (Q3 2019) and $136,196 (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Opus Genetics 381.93 Mn 157.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 25,790.00
Dec 31, 2019 63,605.00
Sep 30, 2019 100,397.00
Jun 30, 2019 136,196.00
Mar 31, 2019 181,490.00
API Access

Opus Genetics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=IRD&period=max&api_key=YOUR_API_KEY